scholarly journals Variation in colon cancer survival for patients living and receiving care in London, 2006–2013: does where you live matter?

2021 ◽  
pp. jech-2021-217043
Author(s):  
Manuela Quaresma ◽  
James R Carpenter ◽  
Adrian Turculet ◽  
Bernard Rachet

BackgroundMarked geographical disparities in survival from colon cancer have been consistently described in England. Similar patterns have been observed within London, almost mimicking a microcosm of the country’s survival patterns. This evidence has suggested that the area of residence plays an important role in the survival from cancer.MethodsWe analysed the survival from colon cancer of patients diagnosed in 2006–2013, in a pre-pandemic period, living in London at their diagnosis and received care in a London hospital. We examined the patterns of patient pathways between the area of residence and the hospital of care using flow maps, and we investigated whether geographical variations in survival from colon cancer are associated with the hospital of care. To estimate survival, we applied a Bayesian excess hazard model which accounts for the hierarchical structure of the data.ResultsGeographical disparities in colon cancer survival disappeared once controlled for hospitals, and the disparities seemed to be augmented between hospitals. However, close examination of patient pathways revealed that the poorer survival observed in some hospitals was mostly associated with higher proportions of emergency diagnosis, while their performance was generally as expected for patients diagnosed through non-emergency routes.DiscussionThis study highlights the need to better coordinate primary and secondary care sectors in some areas of London to improve timely access to specialised clinicians and diagnostic tests. This challenge remains crucially relevant after the recent successive regroupings of Clinical Commissioning Groups (which grouped struggling areas together) and the observed exacerbation of disparities during the COVID-19 pandemic.

2018 ◽  
Vol 61 (5) ◽  
pp. 538-546 ◽  
Author(s):  
Dianne Pulte ◽  
Lina Jansen ◽  
Hermann Brenner

Author(s):  
Ruth McNerney ◽  
Kimberly Sollis ◽  
Rosanna W. Peeling

A new generation of diagnostic tests is being developed for use at the point of care that could save lives and reduce the spread of infectious diseases through early detection and treatment. It is important that patients in developing countries have access to these products at affordable prices and without delay. Regulation of medical products is intended to ensure safety and quality whilst balancing the need for timely access to beneficial new products. Current regulatory oversight of diagnostic tests in developing countries is highly variable and weak regulation allows poor-quality tests to enter the market. However, inefficient orover zealous regulation results in unnecessary delays, increases costs and acts as a barrier to innovation and market entry. Setting international standards and streamlining the regulatory process could reduce these barriers. Four priority activities have been identified where convergence of standards and protocols or joint review of data would be advantageous: (1) adoption of a common registration file for pre-market approval; (2) convergence of quality standards for manufacturing site inspections; (3) use of common evaluation protocols, aswell as joint review of data, to reduce unnecessary duplication of lengthy and costly clinical performance studies; and (4) use of networks of laboratories for post-market surveillance in order to monitor ongoing quality of diagnostic devices. The adoption and implementation of such measures in developing countries could accelerate access to new diagnostic tests that are safe and affordable.


Cancer ◽  
2017 ◽  
Vol 123 ◽  
pp. 5014-5036 ◽  
Author(s):  
Arica White ◽  
Djenaba Joseph ◽  
Sun Hee Rim ◽  
Christopher J. Johnson ◽  
Michel P. Coleman ◽  
...  

Author(s):  
Satish Keshav ◽  
Alexandra Kent

Acute abdominal pain is pain which is below the chest and above the pelvic brim and which has been present for ≤4 weeks. However, typically, patients present within hours of the onset of pain. The differential diagnosis does not differ much in primary and secondary care, although patients in hospital are probably more likely to be prone to iatrogenic illnesses such as pancreatitis, intestinal ischaemia, and Clostridium difficile-associated colitis. This chapter covers the approach to diagnosis, key diagnostic tests, therapies, prognosis, and dealing with uncertainty.


2013 ◽  
Vol 22 (6) ◽  
pp. 1030-1036 ◽  
Author(s):  
Abegail A. Andaya ◽  
Lindsey Enewold ◽  
Shelia H. Zahm ◽  
Craig D. Shriver ◽  
Alexander Stojadinovic ◽  
...  

2008 ◽  
Vol 27 (10) ◽  
pp. 940-949 ◽  
Author(s):  
O. DEJARDIN ◽  
A. M. BOUVIER ◽  
J. FAIVRE ◽  
S. BOUTREUX ◽  
G. DE POUVOURVILLE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document